Neo Ivy Capital Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,886
Closed -$161K 483
2026
Q1
$161K Buy
+9,886
New +$155K 0.04% 273
2025
Q2
Sell
-8,386
Closed -$140K 460
2025
Q1
$140K Sell
8,386
-25,913
-76% -$477K 0.04% 233
2024
Q4
$646K Buy
34,299
+34,280
+180,421% +$661K 0.13% 163
2024
Q3
$0 Buy
+19
New +$364 ﹤0.01% 382
2022
Q4
Sell
-5,048
Closed -$60K 519
2022
Q3
$60K Buy
+5,048
New +$71.7K 0.16% 203
2022
Q1
Sell
-8,191
Closed -$130K 578
2021
Q4
$130K Sell
8,191
-3,212
-28% -$54.8K 0.19% 194
2021
Q3
$91K Buy
+11,403
New +$226K 0.1% 258
2021
Q2
Sell
-1,132
Closed -$21K 594
2021
Q1
$21K Buy
+1,132
New +$18.6K 0.02% 397
2020
Q4
Sell
-848
Closed -$9K 557
2020
Q3
$9K Sell
848
-10,555
-93% -$104K 0.01% 428
2020
Q2
$91K Sell
11,403
-6,741
-37% -$55.8K 0.1% 258
2020
Q1
$147K Buy
+18,144
New +$216K 0.24% 168

Other funds holding SEM

Neo Ivy Capital Management's SEM Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Select Medical (SEM) in Q2 2026, closing a stake of 9,886 shares — an estimated $161K sold.

Neo Ivy Capital Management first reported a position in SEM in Q1 2020 and held it in 11 quarters. The position peaked at $646K in Q4 2024. 240 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Neo Ivy Capital Management reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
  • Neo Ivy Capital Management sold 9,886 Select Medical shares in Q2 2026, an estimated $161K.
  • Neo Ivy Capital Management first reported a position in Select Medical in Q1 2020 and held it in 11 quarters.
  • Neo Ivy Capital Management's Select Medical position peaked at $646K in Q4 2024.
  • 240 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.